University of Bristol Enterprise Fund III Overview

  • Fund Type
  • Venture

  • Fund Status
  • Fully Invested

  • Vintage
  • 2019

Vintage

  • Dry Powder

University of Bristol Enterprise Fund III General Information

Description

University of Bristol Enterprise Fund III is a 2019 vintage early-stage venture capital fund managed by Parkwalk Advisors. The fund is located in London, United Kingdom, and invested in United Kingdom. The fund targeted technology sector.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Fund Family
University of Bristol Enterprise Fund
Native Currency
GBP
Fund Manager's Location
  • 3 Pancras Square
  • Kings Cross
  • London N1C 4AG
  • England, United Kingdom
+44 020
Fund Domiciles
United Kingdom

University of Bristol Enterprise Fund III Investments (6)

University of Bristol Enterprise Fund III has made a total of 6 investments. Its most recent deal was a with Ceryx Medical for . The deal was made on 22-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ceryx Medical 22-Sep-2020 Therapeutic Devices Pre-Clinical Trials
LettUs Grow 09-Jan-2020 Other Agriculture Generating Revenue
Hone Bio 25-Nov-2019 Drug Discovery Generating Revenue
Industrial Phycology 06-Nov-2019 Environmental Services (B2B) Generating Revenue
Inductosense 17-Oct-2019 Early Stage VC Electronic Equipment and Instruments Generating Revenue
Mogrify 14-Oct-2019 Early Stage VC (Series A) Biotechnology Startup
To view University of Bristol Enterprise Fund III’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

University of Bristol Enterprise Fund III Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

University of Bristol Enterprise Fund III Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

University of Bristol Enterprise Fund III FAQs

  • What is University of Bristol Enterprise Fund III?

    University of Bristol Enterprise Fund III is a 2019 vintage early-stage venture capital fund managed by Parkwalk Advisors.

  • Who manages University of Bristol Enterprise Fund III?

    University of Bristol Enterprise Fund III is managed by Parkwalk Advisors.

  • Where is University of Bristol Enterprise Fund III domiciled?

    University of Bristol Enterprise Fund III is domiciled in United Kingdom.

  • What type of fund is University of Bristol Enterprise Fund III?

    The fund type of University of Bristol Enterprise Fund III is Venture.

  • What is the status of University of Bristol Enterprise Fund III?

    University of Bristol Enterprise Fund III is fully invested.

  • What has University of Bristol Enterprise Fund III invested in?

    University of Bristol Enterprise Fund III has made numerous investments in companies like Ceryx Medical, LettUs Grow, and Hone Bio within the Therapeutic Devices, Agriculture, and Drug Discovery industries.

  • What has University of Bristol Enterprise Fund III invested in recently?

    University of Bristol Enterprise Fund III's latest investment was on 22-Sep-2020 in Ceryx Medical, a company within the Therapeutic Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »